DY
NVS icon

Dowling & Yahnke’s Novartis NVS Stock Holding History

Dowling & Yahnke’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,602
Closed -$246K – 342
2020
Q4 		$246K Sell
2,602
-106
-4% -$9.26K 0.02% 299
2020
Q3 		$235K Buy
2,708
+400
+17% +$34.7K 0.02% 287
2020
Q2 		$202K Buy
+2,308
New +$199K 0.02% 290
2020
Q1 		– Sell
-2,452
Closed -$232K – 359
2019
Q4 		$232K Sell
2,452
-41
-2% -$3.68K 0.02% 286
2019
Q3 		$217K Hold
2,493
– – 0.02% 291
2019
Q2 		$228K Sell
2,493
-128
-5% -$10.8K 0.02% 277
2019
Q1 		$226K Buy
2,621
+160
+7% +$12.8K 0.02% 245
2018
Q4 		$202K Buy
+2,461
New +$192K 0.02% 243
2018
Q1 		– Sell
-2,834
Closed -$213K – 290
2017
Q4 		$213K Hold
2,834
– – 0.02% 281
2017
Q3 		$218K Sell
2,834
-159
-5% -$12K 0.02% 269
2017
Q2 		$224K Sell
2,993
-414
-12% -$29.3K 0.02% 262
2017
Q1 		$227K Buy
+3,407
New +$227K 0.02% 259
2016
Q4 		– Sell
-2,875
Closed -$203K – 270
2016
Q3 		$203K Sell
2,875
-202
-7% -$14.7K 0.02% 255
2016
Q2 		$227K Buy
+3,077
New +$213K 0.03% 251
2016
Q1 		– Sell
-5,334
Closed -$411K – 261
2015
Q4 		$411K Buy
5,334
+2,483
+87% +$197K 0.05% 208
2015
Q3 		$235K Buy
2,851
+158
+6% +$14.1K 0.03% 236
2015
Q2 		$237K Hold
2,693
– – 0.03% 242
2015
Q1 		$238K Sell
2,693
-255
-9% -$22.6K 0.03% 235
2014
Q4 		$245K Buy
2,948
+98
+3% +$8.12K 0.03% 238
2014
Q3 		$240K Sell
2,850
-175
-6% -$14.2K 0.03% 229
2014
Q2 		$245K Buy
3,025
+296
+11% +$23.3K 0.03% 245
2014
Q1 		$208K Buy
+2,729
New +$199K 0.03% 263

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Dowling & Yahnke's NVS Position: Q1 2021 in Review

Dowling & Yahnke sold out of Novartis (NVS) in Q1 2021, closing a stake of 2,602 shares — an estimated $246K sold.

Dowling & Yahnke first reported a position in NVS in Q1 2014 and held it in 22 quarters. The position peaked at $411K in Q4 2015. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2021.

  • Dowling & Yahnke reported no remaining Novartis position as of Q1 2021 after selling out during the quarter.
  • Dowling & Yahnke sold 2,602 Novartis shares in Q1 2021, an estimated $246K.
  • Dowling & Yahnke first reported a position in Novartis in Q1 2014 and held it in 22 quarters.
  • Dowling & Yahnke's Novartis position peaked at $411K in Q4 2015.
  • 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2021.

Based on Dowling & Yahnke's 13F filing for Q1 2021, filed 29 Apr 2021.